Improved stability of insulin delivery from implanted pumps using a new preparation process for infused insulin [1]

Diabetes Care

Volumn 22, Issue 8, 1999, Pages 1371-1372

  Renard, Eric ^a   Souche, Céline ^a   Jacques Apostol, Dominique ^a   Lauton, Dominique ^a   Gibert Boulet, Françoise ^a   Costalat, Guy ^a   Bringer, Jacques ^a   Jaffiol, Claude ^a  

^a LAPEYRONIE HOSPITAL   (France)

Author keywords

[No Author keywords available]

Indexed keywords

GLUCOSE; HEMOGLOBIN A1C; HOE 21; INSULIN; NEUTRAL INSULIN; SODIUM HYDROXIDE; UNCLASSIFIED DRUG;

DIABETES CONTROL; DIABETES MELLITUS; DRUG DELIVERY SYSTEM; DRUG STABILITY; GLUCOSE BLOOD LEVEL; HUMAN; HYPOGLYCEMIA; INSULIN BLOOD LEVEL; INSULIN INFUSION; INSULIN PUMP; LETTER; SUBCUTANEOUS DRUG ADMINISTRATION;

FEMALE; HUMANS; HYPOGLYCEMIC AGENTS; INFUSION PUMPS, IMPLANTABLE; INSULIN; MALE;

EID: 0032813998     PISSN: 01495992     EISSN: None     Source Type: Journal    
DOI: 10.2337/diacare.22.8.1371     Document Type: Letter

References (2)

1. Jaremko J, Rorstad O: Advances toward the implantable artificial pancreas for treatment of diabetes. Diabetes Care 21: 444-450, 1998
2. Renard E, Bouteleau S, Jacques-Apostol D, Lauton D, Gibert-Boulet F, Costalat G, Bringer B, Jaffiol C: Insulin underdelivery from implanted pumps using peritoneal route: determinant role of insulin pump compatibility. Diabetes Care 19:812-817, 1996